Management of febrile neutropenia: ESMO Clinical Recommendations
نویسندگان
چکیده
منابع مشابه
Management of febrile neutropenia: ESMO clinical recommendations.
Despite major advances in prevention and treatment, febrile neutropenia (FN) remains one of the most feared complications of cancer chemotherapy, and is a major cause of morbidity, healthcare resource use, and results in delays and dose reductions in chemotherapy which compromise efficacy. Mortality from FN has diminished steadily but remains significant. Overall mortality rates are 5% in patie...
متن کاملManagement of cancer pain: ESMO clinical recommendations.
Over 80% of cancer patients with advanced metastatic disease suffer pain caused mostly by direct tumor infiltration. Pain undermines quality of life considerably and is a clinically important indicator of tumor progression. Cancer pain may be acute or chronic and should be addressed accordingly. Approximately 20% of pain in cancer patients may be attributed to the effects of surgery, radiothera...
متن کاملManagement of Febrile Neutropenia
Bacterial Pathogens Bacteria are the predominant organisms. In the late 1950’s/early 1960’s Gram+ve organisms were the commonest, particularly Staphylococcus aureus. The late 1960’s/early 1970’s were typified by Gram-ve of gastrointestinal tract origin, particularly Escherischia coli, Klebsiella spp and Pseudomonas spp. By the 1990’s Staphylococcus spp including coagulase negative organisms, St...
متن کاملManagement of febrile neutropaenia: ESMO Clinical Practice Guidelines.
Management of febrile neutropenia: ESMO Clinical Practice Guidelines J. de Naurois, I. Novitzky-Basso, M. J. Gill, F. Marti Marti, M. H. Cullen & F. Roila On behalf of the ESMO Guidelines Working Group* Department of Medical Oncology; Department of Haematology; Department of Clinical Microbiology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK; Department of Medical Oncolog...
متن کاملManagement of oral and gastrointestinal mucositis: ESMO clinical recommendations.
Management of oral and gastrointestinal mucositis: ESMO Clinical Recommendations D. E. Peterson, R.-J. Bensadoun & F. Roila On behalf of the ESMO Guidelines Working Group* Department of Oral Health and Diagnostic Sciences, School of Dental Medicine, Head and Neck/Oral Oncology Program, Neag Comprehensive Cancer Center, Farmington, USA; Department of Radiation Oncology, Centre Antoine-Lacassagne...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2009
ISSN: 0923-7534
DOI: 10.1093/annonc/mdp163